Deep, qualified subsequent-technology sequencing has exposed that subclonal mutations (i.e., Individuals existing in just a fraction of tumor cells) is often detected for all driver genes and therefore are related to quick disease development and bad result.eleven–13 This is especially pertinent for TP53Not all clients with CLL have to have thera